Senior insider sale
Chief Medical Officer at VERICEL CORP — senior position signals high conviction
$758.6K
20K shares
What this filing means
HOPPER JONATHAN MARK plans to sell 20K shares of VERICEL CORP valued at approximately $758.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2025ACC: 0001959173-25-005671
Officer· Chief Medical Officer
Since Feb 2020
20K
Shares to sell
$758.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Option Granted - 02/11/2020
Cash
9/2/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2025 | Option Granted - 02/11/2020 Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$400.9K
6/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$357.7K
9/2/2025
Total
Units
20K
Value
$758.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2025 | 10K | $400.9K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2025 | 10K | $357.7K | NASDAQ | Planned |
| Total | 20K | $758.6K | ||